

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of chronic inflammatory response (GO:0002676) | 9.15588113 |
| 2 | single fertilization (GO:0007338) | 8.66929763 |
| 3 | tryptophan catabolic process (GO:0006569) | 8.61730290 |
| 4 | indole-containing compound catabolic process (GO:0042436) | 8.61730290 |
| 5 | indolalkylamine catabolic process (GO:0046218) | 8.61730290 |
| 6 | heterotypic cell-cell adhesion (GO:0034113) | 8.57532381 |
| 7 | positive regulation of type 2 immune response (GO:0002830) | 7.49401906 |
| 8 | negative regulation of interleukin-10 production (GO:0032693) | 7.41050029 |
| 9 | tryptophan metabolic process (GO:0006568) | 7.40716230 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 5.90324882 |
| 11 | fertilization (GO:0009566) | 5.72117947 |
| 12 | amine catabolic process (GO:0009310) | 5.54389134 |
| 13 | cellular biogenic amine catabolic process (GO:0042402) | 5.54389134 |
| 14 | indolalkylamine metabolic process (GO:0006586) | 5.42884090 |
| 15 | negative regulation of interleukin-8 production (GO:0032717) | 5.28079762 |
| 16 | benzene-containing compound metabolic process (GO:0042537) | 4.85076306 |
| 17 | digestion (GO:0007586) | 4.65416251 |
| 18 | epithelial cell morphogenesis (GO:0003382) | 4.40170683 |
| 19 | negative regulation of T cell apoptotic process (GO:0070233) | 4.37621581 |
| 20 | negative regulation of endopeptidase activity (GO:0010951) | 4.37525268 |
| 21 | positive regulation of cell-cell adhesion (GO:0022409) | 4.34122975 |
| 22 | aromatic amino acid family metabolic process (GO:0009072) | 4.29289241 |
| 23 | negative regulation of peptidase activity (GO:0010466) | 4.17553617 |
| 24 | transepithelial transport (GO:0070633) | 3.98325659 |
| 25 | regulation of type 2 immune response (GO:0002828) | 3.89586038 |
| 26 | indole-containing compound metabolic process (GO:0042430) | 3.88084547 |
| 27 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.80321113 |
| 28 | reverse cholesterol transport (GO:0043691) | 3.69908887 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 3.63366582 |
| 30 | defense response to bacterium (GO:0042742) | 3.55061737 |
| 31 | N-acetylneuraminate metabolic process (GO:0006054) | 3.45526432 |
| 32 | negative regulation of protein autophosphorylation (GO:0031953) | 3.32528676 |
| 33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.30449362 |
| 34 | phospholipid homeostasis (GO:0055091) | 3.22760866 |
| 35 | alpha-linolenic acid metabolic process (GO:0036109) | 3.13365770 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.11594804 |
| 37 | response to bacterium (GO:0009617) | 3.06723049 |
| 38 | regulation of macrophage activation (GO:0043030) | 3.03268276 |
| 39 | seminiferous tubule development (GO:0072520) | 25.2954293 |
| 40 | regulation of lipoprotein metabolic process (GO:0050746) | 2.99181833 |
| 41 | negative regulation of proteolysis (GO:0045861) | 2.83895291 |
| 42 | glial cell proliferation (GO:0014009) | 2.81390931 |
| 43 | cysteine metabolic process (GO:0006534) | 2.80450143 |
| 44 | negative regulation of protein maturation (GO:1903318) | 2.73786735 |
| 45 | negative regulation of protein processing (GO:0010955) | 2.73786735 |
| 46 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.73560285 |
| 47 | regulation of activated T cell proliferation (GO:0046006) | 2.72834363 |
| 48 | sialylation (GO:0097503) | 2.72481011 |
| 49 | regulation of beta-amyloid formation (GO:1902003) | 2.71838378 |
| 50 | complement activation, alternative pathway (GO:0006957) | 2.71639232 |
| 51 | O-glycan processing (GO:0016266) | 2.69117410 |
| 52 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.67454118 |
| 53 | high-density lipoprotein particle remodeling (GO:0034375) | 2.66754672 |
| 54 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.59541197 |
| 55 | low-density lipoprotein particle clearance (GO:0034383) | 2.58822127 |
| 56 | positive regulation of interleukin-12 production (GO:0032735) | 2.55732592 |
| 57 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.54601021 |
| 58 | hormone catabolic process (GO:0042447) | 2.53543161 |
| 59 | negative regulation of hydrolase activity (GO:0051346) | 2.53126950 |
| 60 | negative regulation of glycogen metabolic process (GO:0070874) | 2.47325072 |
| 61 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.47226699 |
| 62 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.45240508 |
| 63 | L-serine transport (GO:0015825) | 2.36294012 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 2.35708473 |
| 65 | valine metabolic process (GO:0006573) | 2.35301172 |
| 66 | regulation of endopeptidase activity (GO:0052548) | 2.34290421 |
| 67 | lipid catabolic process (GO:0016042) | 2.32852281 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 2.28078967 |
| 69 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.27568341 |
| 70 | negative regulation of interleukin-6 production (GO:0032715) | 2.26546773 |
| 71 | response to misfolded protein (GO:0051788) | 2.25797155 |
| 72 | triglyceride catabolic process (GO:0019433) | 2.25401689 |
| 73 | regulation of peptidase activity (GO:0052547) | 2.22663128 |
| 74 | regulation of T cell apoptotic process (GO:0070232) | 2.22116272 |
| 75 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.21194935 |
| 76 | L-phenylalanine catabolic process (GO:0006559) | 2.21194935 |
| 77 | acylglycerol catabolic process (GO:0046464) | 2.19000884 |
| 78 | neutral lipid catabolic process (GO:0046461) | 2.19000884 |
| 79 | plasma lipoprotein particle remodeling (GO:0034369) | 2.15062393 |
| 80 | protein-lipid complex remodeling (GO:0034368) | 2.15062393 |
| 81 | macromolecular complex remodeling (GO:0034367) | 2.15062393 |
| 82 | COPI coating of Golgi vesicle (GO:0048205) | 2.12681432 |
| 83 | Golgi transport vesicle coating (GO:0048200) | 2.12681432 |
| 84 | positive regulation of cholesterol transport (GO:0032376) | 2.11651133 |
| 85 | positive regulation of sterol transport (GO:0032373) | 2.11651133 |
| 86 | regulation of interleukin-10 production (GO:0032653) | 2.09429820 |
| 87 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.08861621 |
| 88 | myelin maintenance (GO:0043217) | 2.08154488 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 2.07046991 |
| 90 | glutamate metabolic process (GO:0006536) | 2.06735313 |
| 91 | negative regulation of T cell proliferation (GO:0042130) | 2.05438393 |
| 92 | serine transport (GO:0032329) | 2.04049022 |
| 93 | regulation of lipoprotein particle clearance (GO:0010984) | 2.02791469 |
| 94 | activation of protein kinase A activity (GO:0034199) | 2.01838984 |
| 95 | production of molecular mediator involved in inflammatory response (GO:0002532) | 14.4536916 |
| 96 | regulation of T cell tolerance induction (GO:0002664) | 14.4425541 |
| 97 | positive regulation of tolerance induction (GO:0002645) | 12.3842659 |
| 98 | sperm capacitation (GO:0048240) | 11.2277398 |
| 99 | regulation of tolerance induction (GO:0002643) | 10.7777203 |
| 100 | kynurenine metabolic process (GO:0070189) | 10.5441088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 4.89355318 |
| 2 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.39356617 |
| 3 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 4.10416044 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.26630669 |
| 5 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.24743191 |
| 6 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.74795463 |
| 7 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.68218425 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.67673937 |
| 9 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.63890768 |
| 10 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.61924776 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.52234296 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.42360735 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37220885 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.14850462 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.14419103 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.07161686 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94974497 |
| 18 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.92571348 |
| 19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82256094 |
| 20 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.81194219 |
| 21 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.77584666 |
| 22 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74893192 |
| 23 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.73545556 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.71287618 |
| 25 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.69621776 |
| 26 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.68525129 |
| 27 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.64660563 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.61873695 |
| 29 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.59744466 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56800963 |
| 31 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.55215794 |
| 32 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.53834259 |
| 33 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.52776307 |
| 34 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.52467878 |
| 35 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.49838959 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48583183 |
| 37 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.43005207 |
| 38 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42116685 |
| 39 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.41940901 |
| 40 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.35910972 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.35172301 |
| 42 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33863132 |
| 43 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29003433 |
| 44 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22282018 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21822963 |
| 46 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.19323547 |
| 47 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.18888009 |
| 48 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.17376943 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16933132 |
| 50 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.15619059 |
| 51 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.13036227 |
| 52 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12463649 |
| 53 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.12253209 |
| 54 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.11185625 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10991330 |
| 56 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.10378418 |
| 57 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08706827 |
| 58 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07840863 |
| 59 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06140576 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05282501 |
| 61 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.03556231 |
| 62 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03388790 |
| 63 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.02237118 |
| 64 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.01152852 |
| 65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99441116 |
| 66 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.99339617 |
| 67 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98075078 |
| 68 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98075078 |
| 69 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.97901124 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96984684 |
| 71 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95771183 |
| 72 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.95477351 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95375971 |
| 74 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95078963 |
| 75 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.94601762 |
| 76 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.94561440 |
| 77 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94049801 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93566073 |
| 79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93300327 |
| 80 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93261771 |
| 81 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92717134 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92580493 |
| 83 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91766976 |
| 84 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.91622310 |
| 85 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91458678 |
| 86 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90122367 |
| 87 | * P68_20966046_ChIP-Seq_HELA_Human | 0.89608797 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89484176 |
| 89 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.88383330 |
| 90 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.87989412 |
| 91 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.86721501 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86390622 |
| 93 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84054545 |
| 94 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.81747452 |
| 95 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.80885944 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80678679 |
| 97 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.80639863 |
| 98 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80092050 |
| 99 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.79733003 |
| 100 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.79614153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.72991931 |
| 2 | MP0003195_calcinosis | 5.18795908 |
| 3 | MP0002254_reproductive_system_inflammat | 4.96786872 |
| 4 | MP0004043_abnormal_pH_regulation | 4.71638266 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 4.25629752 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 4.18029360 |
| 7 | MP0005410_abnormal_fertilization | 3.33386619 |
| 8 | MP0005058_abnormal_lysosome_morphology | 3.24804019 |
| 9 | MP0003329_amyloid_beta_deposits | 3.11816559 |
| 10 | MP0000003_abnormal_adipose_tissue | 2.20122803 |
| 11 | MP0005360_urolithiasis | 2.15253957 |
| 12 | MP0000604_amyloidosis | 2.11697945 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.09411110 |
| 14 | MP0002168_other_aberrant_phenotype | 1.99566441 |
| 15 | MP0005365_abnormal_bile_salt | 1.85194845 |
| 16 | MP0003566_abnormal_cell_adhesion | 1.77766259 |
| 17 | MP0003300_gastrointestinal_ulcer | 1.72010051 |
| 18 | MP0004885_abnormal_endolymph | 1.70423469 |
| 19 | MP0001501_abnormal_sleep_pattern | 1.60743255 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 1.58017615 |
| 21 | MP0004130_abnormal_muscle_cell | 1.56798578 |
| 22 | MP0001765_abnormal_ion_homeostasis | 1.53569068 |
| 23 | MP0005375_adipose_tissue_phenotype | 1.52945802 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.51950938 |
| 25 | MP0004859_abnormal_synaptic_plasticity | 1.51949196 |
| 26 | MP0001440_abnormal_grooming_behavior | 1.51725583 |
| 27 | MP0001853_heart_inflammation | 1.43943892 |
| 28 | MP0003690_abnormal_glial_cell | 1.39030228 |
| 29 | MP0000534_abnormal_ureter_morphology | 1.38639792 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.36180106 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.34890784 |
| 32 | MP0004858_abnormal_nervous_system | 1.33819382 |
| 33 | MP0005332_abnormal_amino_acid | 1.33064692 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.29658249 |
| 35 | MP0005083_abnormal_biliary_tract | 1.24354793 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.20297418 |
| 37 | MP0001756_abnormal_urination | 1.19435098 |
| 38 | MP0002089_abnormal_postnatal_growth/wei | 1.17728169 |
| 39 | MP0000537_abnormal_urethra_morphology | 1.17689214 |
| 40 | MP0008438_abnormal_cutaneous_collagen | 1.17421072 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16390371 |
| 42 | MP0005275_abnormal_skin_tensile | 1.10346237 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.09290774 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.09050984 |
| 45 | MP0002896_abnormal_bone_mineralization | 1.06065661 |
| 46 | MP0004270_analgesia | 1.04949024 |
| 47 | MP0002796_impaired_skin_barrier | 1.04294150 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 0.99810078 |
| 49 | MP0003252_abnormal_bile_duct | 0.99592085 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 0.96946917 |
| 51 | MP0003632_abnormal_nervous_system | 0.96749121 |
| 52 | MP0002909_abnormal_adrenal_gland | 0.95213156 |
| 53 | MP0008875_abnormal_xenobiotic_pharmacok | 0.95195706 |
| 54 | MP0005666_abnormal_adipose_tissue | 0.94279590 |
| 55 | MP0003075_altered_response_to | 0.93622242 |
| 56 | MP0000920_abnormal_myelination | 0.92923114 |
| 57 | MP0003698_abnormal_male_reproductive | 0.92855089 |
| 58 | MP0003879_abnormal_hair_cell | 0.87748761 |
| 59 | MP0000747_muscle_weakness | 0.87017946 |
| 60 | MP0002733_abnormal_thermal_nociception | 0.84239824 |
| 61 | MP0002136_abnormal_kidney_physiology | 0.83672504 |
| 62 | MP0009840_abnormal_foam_cell | 0.83414818 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 0.83353967 |
| 64 | MP0000609_abnormal_liver_physiology | 0.79495279 |
| 65 | MP0002876_abnormal_thyroid_physiology | 0.79082600 |
| 66 | MP0004036_abnormal_muscle_relaxation | 0.78433389 |
| 67 | MP0002933_joint_inflammation | 0.78269386 |
| 68 | MP0003631_nervous_system_phenotype | 0.77096146 |
| 69 | MP0003635_abnormal_synaptic_transmissio | 0.76511399 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 0.75061934 |
| 71 | MP0003633_abnormal_nervous_system | 0.73791652 |
| 72 | MP0005395_other_phenotype | 0.73044308 |
| 73 | MP0005670_abnormal_white_adipose | 0.68549183 |
| 74 | MP0002735_abnormal_chemical_nociception | 0.68077465 |
| 75 | MP0010678_abnormal_skin_adnexa | 0.64576278 |
| 76 | MP0003634_abnormal_glial_cell | 0.64286599 |
| 77 | MP0005535_abnormal_body_temperature | 0.62891057 |
| 78 | MP0000538_abnormal_urinary_bladder | 0.62537336 |
| 79 | MP0002272_abnormal_nervous_system | 0.62527290 |
| 80 | MP0005334_abnormal_fat_pad | 0.62178128 |
| 81 | MP0000462_abnormal_digestive_system | 0.61232104 |
| 82 | MP0009384_cardiac_valve_regurgitation | 0.60567065 |
| 83 | MP0005623_abnormal_meninges_morphology | 0.60540833 |
| 84 | MP0001970_abnormal_pain_threshold | 0.59723022 |
| 85 | MP0000249_abnormal_blood_vessel | 0.59418631 |
| 86 | MP0002295_abnormal_pulmonary_circulatio | 0.59018182 |
| 87 | MP0002971_abnormal_brown_adipose | 0.58859143 |
| 88 | MP0001666_abnormal_nutrient_absorption | 0.58669265 |
| 89 | MP0009053_abnormal_anal_canal | 0.56382718 |
| 90 | MP0002653_abnormal_ependyma_morphology | 0.55035610 |
| 91 | MP0000013_abnormal_adipose_tissue | 0.54786875 |
| 92 | MP0000751_myopathy | 0.54685565 |
| 93 | MP0004272_abnormal_basement_membrane | 0.53951755 |
| 94 | MP0002064_seizures | 0.53644195 |
| 95 | MP0005166_decreased_susceptibility_to | 0.51933074 |
| 96 | MP0002161_abnormal_fertility/fecundity | 0.51409408 |
| 97 | MP0004084_abnormal_cardiac_muscle | 0.50477799 |
| 98 | MP0004087_abnormal_muscle_fiber | 0.50180859 |
| 99 | MP0001177_atelectasis | 0.49899508 |
| 100 | MP0003959_abnormal_lean_body | 0.49069831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myocardial infarction (HP:0001658) | 5.39761550 |
| 2 | Hypophosphatemic rickets (HP:0004912) | 5.04916185 |
| 3 | Facial shape deformation (HP:0011334) | 4.76712085 |
| 4 | Potter facies (HP:0002009) | 4.76712085 |
| 5 | Vascular calcification (HP:0004934) | 4.72699351 |
| 6 | Complement deficiency (HP:0004431) | 4.59746364 |
| 7 | Cardiovascular calcification (HP:0011915) | 4.40527328 |
| 8 | Neurofibrillary tangles (HP:0002185) | 4.35996978 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 4.22748068 |
| 10 | Malnutrition (HP:0004395) | 3.97152480 |
| 11 | Choroideremia (HP:0001139) | 3.73020806 |
| 12 | Neoplasm of the heart (HP:0100544) | 3.55810259 |
| 13 | Abnormality of complement system (HP:0005339) | 3.34368929 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.23294672 |
| 15 | Xanthomatosis (HP:0000991) | 3.20898924 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.20785055 |
| 17 | Infantile muscular hypotonia (HP:0008947) | 3.20012563 |
| 18 | Widely patent fontanelles and sutures (HP:0004492) | 3.17626174 |
| 19 | Intention tremor (HP:0002080) | 3.14489551 |
| 20 | Rickets (HP:0002748) | 3.11553043 |
| 21 | Deep venous thrombosis (HP:0002625) | 3.06575145 |
| 22 | Choreoathetosis (HP:0001266) | 3.04167736 |
| 23 | Agitation (HP:0000713) | 3.02652964 |
| 24 | Hemiplegia (HP:0002301) | 2.74998313 |
| 25 | Ketoacidosis (HP:0001993) | 2.68089052 |
| 26 | Ketosis (HP:0001946) | 2.48962474 |
| 27 | Difficulty running (HP:0009046) | 2.48752196 |
| 28 | Abnormality of the fovea (HP:0000493) | 2.48169353 |
| 29 | Polar cataract (HP:0010696) | 2.43913463 |
| 30 | Gout (HP:0001997) | 2.42379589 |
| 31 | Intrahepatic cholestasis (HP:0001406) | 2.42141100 |
| 32 | Hyperglycinuria (HP:0003108) | 2.38827555 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.37938198 |
| 34 | Hypopigmentation of the fundus (HP:0007894) | 2.37635799 |
| 35 | Hemorrhage of the eye (HP:0011885) | 2.35342434 |
| 36 | Testicular atrophy (HP:0000029) | 2.31699401 |
| 37 | Skin nodule (HP:0200036) | 2.29567718 |
| 38 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.27831402 |
| 39 | Acanthosis nigricans (HP:0000956) | 2.24469003 |
| 40 | Peripheral hypomyelination (HP:0007182) | 2.23705517 |
| 41 | Hyporeflexia of lower limbs (HP:0002600) | 2.22997190 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 2.19972818 |
| 43 | Hyperlipoproteinemia (HP:0010980) | 2.17923892 |
| 44 | Abnormal hemoglobin (HP:0011902) | 2.16782030 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 2.12343073 |
| 46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.12343073 |
| 47 | Epidermoid cyst (HP:0200040) | 2.11169777 |
| 48 | Gait ataxia (HP:0002066) | 2.09884967 |
| 49 | Osteomalacia (HP:0002749) | 2.07509690 |
| 50 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.04575271 |
| 51 | Focal segmental glomerulosclerosis (HP:0000097) | 2.04016325 |
| 52 | Spastic diplegia (HP:0001264) | 2.01245136 |
| 53 | Hepatoblastoma (HP:0002884) | 1.99965687 |
| 54 | Thin bony cortex (HP:0002753) | 1.99544236 |
| 55 | Muscle fiber splitting (HP:0003555) | 1.98392614 |
| 56 | Right ventricular cardiomyopathy (HP:0011663) | 1.96231686 |
| 57 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.95544688 |
| 58 | Myokymia (HP:0002411) | 1.95045689 |
| 59 | Hyperparathyroidism (HP:0000843) | 1.94034714 |
| 60 | Ulnar claw (HP:0001178) | 1.93548933 |
| 61 | Hypoalphalipoproteinemia (HP:0003233) | 1.89532174 |
| 62 | Dysostosis multiplex (HP:0000943) | 1.89408925 |
| 63 | Restlessness (HP:0000711) | 1.89145074 |
| 64 | Hypertriglyceridemia (HP:0002155) | 1.88863961 |
| 65 | Increased connective tissue (HP:0009025) | 1.87361952 |
| 66 | Hyperammonemia (HP:0001987) | 1.87348609 |
| 67 | Prominent nose (HP:0000448) | 1.86426790 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 1.86234392 |
| 69 | Wide cranial sutures (HP:0010537) | 1.85132415 |
| 70 | Ectopia lentis (HP:0001083) | 1.83720457 |
| 71 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.81460437 |
| 72 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.81460437 |
| 73 | Hyperphosphatemia (HP:0002905) | 1.81077318 |
| 74 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.78890817 |
| 75 | Glomerulosclerosis (HP:0000096) | 1.77075997 |
| 76 | Gastrointestinal dysmotility (HP:0002579) | 1.77009719 |
| 77 | Hyperglycinemia (HP:0002154) | 1.75370684 |
| 78 | Hypophosphatemia (HP:0002148) | 1.75115959 |
| 79 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.73604031 |
| 80 | Psychosis (HP:0000709) | 1.72730048 |
| 81 | Progressive neurologic deterioration (HP:0002344) | 1.71957545 |
| 82 | Pili torti (HP:0003777) | 1.71558212 |
| 83 | Increased CSF protein (HP:0002922) | 1.71225996 |
| 84 | Turricephaly (HP:0000262) | 1.70316754 |
| 85 | Oligomenorrhea (HP:0000876) | 1.69567379 |
| 86 | Abnormal cartilage morphology (HP:0002763) | 1.66892372 |
| 87 | Abnormality of the periventricular white matter (HP:0002518) | 1.66524935 |
| 88 | Amyloidosis (HP:0011034) | 1.64469274 |
| 89 | Tubulointerstitial fibrosis (HP:0005576) | 1.64245744 |
| 90 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.63571925 |
| 91 | Abnormality of the Achilles tendon (HP:0005109) | 1.63309823 |
| 92 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.62474506 |
| 93 | Calf muscle hypertrophy (HP:0008981) | 1.60340875 |
| 94 | Back pain (HP:0003418) | 1.59820791 |
| 95 | Subcapsular cataract (HP:0000523) | 1.59643430 |
| 96 | Abnormality of abdominal situs (HP:0011620) | 1.58279847 |
| 97 | Abdominal situs inversus (HP:0003363) | 1.58279847 |
| 98 | Loss of speech (HP:0002371) | 1.57031729 |
| 99 | Abnormality of the corticospinal tract (HP:0002492) | 1.56973984 |
| 100 | Difficulty climbing stairs (HP:0003551) | 1.56654003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 3.72099505 |
| 2 | ERN1 | 3.31263125 |
| 3 | LMTK2 | 3.19940352 |
| 4 | EPHB1 | 2.84587738 |
| 5 | SIK1 | 2.63489057 |
| 6 | PKN2 | 2.49963439 |
| 7 | LRRK2 | 2.34557798 |
| 8 | TRIB3 | 2.21878501 |
| 9 | PDGFRA | 2.19031534 |
| 10 | FER | 2.17960405 |
| 11 | FGFR2 | 2.16268146 |
| 12 | FGFR4 | 1.95106029 |
| 13 | TAOK3 | 1.87246407 |
| 14 | STK39 | 1.87211370 |
| 15 | PRKD3 | 1.82547447 |
| 16 | WNK4 | 1.81062682 |
| 17 | EPHA2 | 1.60592353 |
| 18 | MAP3K2 | 1.56591490 |
| 19 | PTK6 | 1.48715410 |
| 20 | TNK2 | 1.41375001 |
| 21 | TTN | 1.37560400 |
| 22 | NTRK3 | 1.36388992 |
| 23 | RET | 1.34258424 |
| 24 | TYRO3 | 1.31655482 |
| 25 | PTK2B | 1.28347396 |
| 26 | PAK3 | 1.27379574 |
| 27 | NTRK1 | 1.27239081 |
| 28 | RIPK4 | 1.23793842 |
| 29 | MAP2K4 | 1.18819606 |
| 30 | PTK2 | 1.18578418 |
| 31 | SCYL2 | 1.13910475 |
| 32 | MYLK | 1.12846420 |
| 33 | INSR | 1.12260223 |
| 34 | CDK19 | 1.11471175 |
| 35 | KSR2 | 1.11437839 |
| 36 | PAK6 | 1.11201377 |
| 37 | TESK1 | 1.10960674 |
| 38 | STK10 | 1.08868763 |
| 39 | PRKCH | 1.05876865 |
| 40 | BCKDK | 1.05176912 |
| 41 | FRK | 0.95866347 |
| 42 | FGFR3 | 0.95861372 |
| 43 | LATS2 | 0.92884460 |
| 44 | PDK3 | 0.87035187 |
| 45 | PDK4 | 0.87035187 |
| 46 | ALK | 0.86822712 |
| 47 | MAP3K7 | 0.86245756 |
| 48 | DMPK | 0.85116256 |
| 49 | PAK4 | 0.85104354 |
| 50 | EPHB2 | 0.83538817 |
| 51 | CDK5 | 0.82763342 |
| 52 | PAK2 | 0.82370696 |
| 53 | ICK | 0.82327108 |
| 54 | MAP3K6 | 0.78624547 |
| 55 | EPHA4 | 0.78496706 |
| 56 | MAP3K12 | 0.78327646 |
| 57 | SIK2 | 0.74841766 |
| 58 | MAP2K1 | 0.73911666 |
| 59 | PRKCG | 0.72390877 |
| 60 | NTRK2 | 0.69840815 |
| 61 | WNK1 | 0.69337799 |
| 62 | MINK1 | 0.68750332 |
| 63 | PHKG2 | 0.67972574 |
| 64 | PHKG1 | 0.67972574 |
| 65 | CAMK1G | 0.66839451 |
| 66 | DDR2 | 0.66741364 |
| 67 | AKT3 | 0.66694626 |
| 68 | GSK3A | 0.66458152 |
| 69 | STK38 | 0.64921319 |
| 70 | DAPK2 | 0.64483315 |
| 71 | JAK2 | 0.64147911 |
| 72 | FGFR1 | 0.63358770 |
| 73 | ROCK2 | 0.62698024 |
| 74 | LATS1 | 0.60829257 |
| 75 | SRC | 0.59650403 |
| 76 | PDGFRB | 0.58426723 |
| 77 | FLT3 | 0.58261569 |
| 78 | MAP3K9 | 0.58237304 |
| 79 | PRKD1 | 0.57991007 |
| 80 | EEF2K | 0.57887614 |
| 81 | FYN | 0.57535541 |
| 82 | UHMK1 | 0.56125730 |
| 83 | PRKCZ | 0.55989691 |
| 84 | PRKACG | 0.54931698 |
| 85 | CSNK1E | 0.54190616 |
| 86 | MARK1 | 0.53147920 |
| 87 | CDK6 | 0.51892142 |
| 88 | MET | 0.51253967 |
| 89 | FES | 0.50956337 |
| 90 | ERBB2 | 0.49861003 |
| 91 | EGFR | 0.46678944 |
| 92 | PDK1 | 0.44455315 |
| 93 | PRKCQ | 0.42331666 |
| 94 | PDPK1 | 0.42094354 |
| 95 | CSK | 0.40939061 |
| 96 | MAP3K13 | 0.40398900 |
| 97 | GRK5 | 0.38274953 |
| 98 | RIPK1 | 0.37719162 |
| 99 | DAPK3 | 0.36740465 |
| 100 | JAK1 | 0.36361286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.28075942 |
| 2 | Glutathione metabolism_Homo sapiens_hsa00480 | 4.33747341 |
| 3 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 3.50136644 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 3.47839684 |
| 5 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 3.39799481 |
| 6 | African trypanosomiasis_Homo sapiens_hsa05143 | 3.28819875 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.06465013 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.79073894 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.99936867 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.98113957 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95120397 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.90333732 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.64815689 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63530943 |
| 15 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53108519 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.52952021 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41033891 |
| 18 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.31973889 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.29679413 |
| 20 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.19640800 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16645478 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16597448 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.11348928 |
| 24 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09690282 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09360634 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00957282 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.00894519 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.00676329 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99635522 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 0.99545005 |
| 31 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98844329 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 0.96988293 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.95667962 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95315354 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95063795 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94586827 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92731230 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90438823 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89198922 |
| 40 | GABAergic synapse_Homo sapiens_hsa04727 | 0.86750456 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84647655 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83291729 |
| 43 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83140520 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78262752 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76879773 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76318544 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75721286 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75288694 |
| 49 | Prion diseases_Homo sapiens_hsa05020 | 0.68125855 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67389160 |
| 51 | Circadian entrainment_Homo sapiens_hsa04713 | 0.67129034 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65345879 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63435382 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62763755 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62538943 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62073139 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60537010 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59326435 |
| 59 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58601171 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57806236 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57642470 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56416883 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54866628 |
| 64 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.54657580 |
| 65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52240737 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51486069 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50253650 |
| 68 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.50097145 |
| 69 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46147273 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45103727 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44983163 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44436636 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.43444440 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42416561 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.41500017 |
| 76 | Insulin secretion_Homo sapiens_hsa04911 | 0.40582032 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37992622 |
| 78 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37763187 |
| 79 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.37699561 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37280306 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37035660 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35377593 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34819186 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.34542559 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34476760 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34355486 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.33450182 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33152079 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33106513 |
| 90 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.32135962 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.31124556 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.31114470 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30340053 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.27373844 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.26218843 |
| 96 | Melanogenesis_Homo sapiens_hsa04916 | 0.26105781 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.26034968 |
| 98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.25807578 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23815741 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.22974111 |

